Region: Denmark

Janssen defeats second claim over cancer drug royalties

Belgium’s Janssen Pharmaceuticals has defeated a US$405 million claim brought by a Danish biotech company over a blood cancer treatment – having already won a previous arbitration concerning the same licensing agreement.

21 April 2023

Denmark announces plans to exit ECT

Denmark has signalled its intent to withdraw from the Energy Charter Treaty over concerns it may hinder the transition to green energy, the latest EU member state to join the exodus.

14 April 2023

Finnish state entity brings ICC claim over Russian wind farms

A Finnish state-owned energy company has launched a €200 million ICC arbitration against a Danish wind turbine manufacturer over its termination of Russian projects following the invasion of Ukraine – prompting allegations that the case “undermines EU sanctions”.

12 April 2023

Danish investor pursues claim against Tanzania

A Danish agriculture investor is bringing an investment treaty claim against Tanzania at the Permanent Court of Arbitration, it has emerged.

04 April 2023

Greenland avoids interim measures in mining dispute

An Australian company bringing an arbitration against Greenland over a uranium mining ban has failed to get interim measures to restrain the island country from making a final decision on its bid for an exploitation licence.

26 September 2022

Carlsberg wins South Asian joint venture dispute

A SIAC tribunal chaired by Jan Paulsson has ruled in favour of Carlsberg in a US$1.5 billion dispute relating to its businesses in Nepal and India, giving the Danish brewer the right to buy its partner out of a joint venture.

18 August 2022

Burford-funded mining claim against Greenland underway

A tribunal has begun hearing an Australian company’s claim against Greenland and the Kingdom of Denmark over a uranium mining ban affecting a US$3 billion project – a case financed by a subsidiary of Burford Capital.

29 July 2022

Janssen faces fresh claim over cancer drug royalties

A Danish biotech company has renewed its dispute with Belgium’s Janssen Pharmaceuticals, claiming US$405 million over a blood cancer treatment just weeks after a tribunal dismissed an earlier arbitration concerning the same licensing agreement.

10 June 2022

Janssen secures win in cancer drug royalties dispute

Belgian pharmaceuticals company Janssen has defeated a claim brought by a Danish biotech company over royalties due for a blood cancer treatment.

08 April 2022

Australian miner launches claim against Greenland and Denmark

An Australian miner has filed for arbitration against Greenland and the Kingdom of Denmark over a uranium mining ban that has brought to a halt a billion-dollar rare-earth project.

23 March 2022

Unlock unlimited access to all Global Arbitration Review content